PF-4840154

From WikiMD's Medical Encyclopedia

Revision as of 20:54, 25 February 2025 by Prab (talk | contribs) (CSV import)

PF-4840154 is a drug candidate that was developed by Pfizer for the potential treatment of Type 2 diabetes. It is a potent and selective agonist of the G protein-coupled receptor GPR119, which is expressed in the pancreas and gastrointestinal tract.

History

PF-4840154 was first synthesized by Pfizer in the early 2010s as part of their research into novel treatments for Type 2 diabetes. The drug was designed to target the GPR119 receptor, which had been identified as a promising therapeutic target for the treatment of metabolic disorders.

Mechanism of Action

PF-4840154 works by binding to and activating the GPR119 receptor. This receptor is found in the pancreas and gastrointestinal tract, where it plays a role in regulating glucose metabolism. Activation of the GPR119 receptor by PF-4840154 stimulates the release of insulin and glucagon-like peptide-1 (GLP-1), two hormones that help to regulate blood sugar levels.

Clinical Trials

Pfizer conducted several clinical trials to assess the safety and efficacy of PF-4840154 in patients with Type 2 diabetes. However, the results of these trials have not been publicly disclosed, and it is unclear whether Pfizer plans to continue development of the drug.

Potential Applications

If proven safe and effective, PF-4840154 could offer a new treatment option for patients with Type 2 diabetes. By targeting the GPR119 receptor, the drug could potentially improve blood sugar control and reduce the risk of diabetes-related complications.

See Also

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!

PF-4840154

  • PF-4840154
    PF-4840154
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?

Get started with evidence based, physician-supervised

affordable GLP-1 weight loss injections

Now available in New York City and Philadelphia:

✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends

Learn more:

Start your transformation today with W8MD weight loss centers.

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=PF-4840154&oldid=6347199"